190 related articles for article (PubMed ID: 18223212)
1. Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma.
Boult J; Roberts K; Brookes MJ; Hughes S; Bury JP; Cross SS; Anderson GJ; Spychal R; Iqbal T; Tselepis C
Clin Cancer Res; 2008 Jan; 14(2):379-87. PubMed ID: 18223212
[TBL] [Abstract][Full Text] [Related]
2. Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants.
Lin J; Lin L; Thomas DG; Greenson JK; Giordano TJ; Robinson GS; Barve RA; Weishaar FA; Taylor JM; Orringer MB; Beer DG
Clin Cancer Res; 2004 Sep; 10(17):5708-16. PubMed ID: 15355897
[TBL] [Abstract][Full Text] [Related]
3. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A
Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793
[TBL] [Abstract][Full Text] [Related]
4. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor.
Haigh CR; Attwood SE; Thompson DG; Jankowski JA; Kirton CM; Pritchard DM; Varro A; Dimaline R
Gastroenterology; 2003 Mar; 124(3):615-25. PubMed ID: 12612900
[TBL] [Abstract][Full Text] [Related]
5. Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma.
Hughes SJ; Nambu Y; Soldes OS; Hamstra D; Rehemtulla A; Iannettoni MD; Orringer MB; Beer DG
Cancer Res; 1997 Dec; 57(24):5571-8. PubMed ID: 9407969
[TBL] [Abstract][Full Text] [Related]
6. Proteomic screening of a cell line model of esophageal carcinogenesis identifies cathepsin D and aldo-keto reductase 1C2 and 1B10 dysregulation in Barrett's esophagus and esophageal adenocarcinoma.
Breton J; Gage MC; Hay AW; Keen JN; Wild CP; Donnellan C; Findlay JB; Hardie LJ
J Proteome Res; 2008 May; 7(5):1953-62. PubMed ID: 18396902
[TBL] [Abstract][Full Text] [Related]
7. Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line.
Jaiswal K; Lopez-Guzman C; Souza RF; Spechler SJ; Sarosi GA
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G335-42. PubMed ID: 16239404
[TBL] [Abstract][Full Text] [Related]
8. Expression of glutathione s-transferase pi in benign mucosa, Barrett's metaplasia, and adenocarcinoma of the esophagus.
Chandra RK; Bentz BG; Haines GK; Robinson AM; Radosevich JA
Head Neck; 2002 Jun; 24(6):575-81. PubMed ID: 12112555
[TBL] [Abstract][Full Text] [Related]
9. Modulation of iron transport proteins in human colorectal carcinogenesis.
Brookes MJ; Hughes S; Turner FE; Reynolds G; Sharma N; Ismail T; Berx G; McKie AT; Hotchin N; Anderson GJ; Iqbal T; Tselepis C
Gut; 2006 Oct; 55(10):1449-60. PubMed ID: 16641131
[TBL] [Abstract][Full Text] [Related]
10. Adaptive changes of duodenal iron transport proteins in celiac disease.
Barisani D; Parafioriti A; Bardella MT; Zoller H; Conte D; Armiraglio E; Trovato C; Koch RO; Weiss G
Physiol Genomics; 2004 May; 17(3):316-25. PubMed ID: 15054143
[TBL] [Abstract][Full Text] [Related]
11. Effect of inflammation on cyclooxygenase (COX)-2 expression in benign and malignant oesophageal cells.
Abdalla SI; Sanderson IR; Fitzgerald RC
Carcinogenesis; 2005 Sep; 26(9):1627-33. PubMed ID: 15878911
[TBL] [Abstract][Full Text] [Related]
12. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
13. Change in iron transporter expression in human term placenta with different maternal iron status.
Li YQ; Yan H; Bai B
Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):48-54. PubMed ID: 18586377
[TBL] [Abstract][Full Text] [Related]
14. Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus.
Dvorak K; Chavarria M; Payne CM; Ramsey L; Crowley-Weber C; Dvorakova B; Dvorak B; Bernstein H; Holubec H; Sampliner RE; Bernstein C; Prasad A; Green SB; Garewal H
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5305-13. PubMed ID: 17875759
[TBL] [Abstract][Full Text] [Related]
15. Barrett's esophagus: can biomarkers predict progression to malignancy?
Tischoff I; Tannapfel A
Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):653-63. PubMed ID: 19072343
[TBL] [Abstract][Full Text] [Related]
16. Increased divalent metal transporter 1 expression might be associated with the neurotoxicity of L-DOPA.
Chang YZ; Ke Y; Du JR; Halpern GM; Ho KP; Zhu L; Gu XS; Xu YJ; Wang Q; Li LZ; Wang CY; Qian ZM
Mol Pharmacol; 2006 Mar; 69(3):968-74. PubMed ID: 16317110
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis.
Lao-Sirieix P; Brais R; Lovat L; Coleman N; Fitzgerald RC
Neoplasia; 2004; 6(6):751-60. PubMed ID: 15720801
[TBL] [Abstract][Full Text] [Related]
18. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
19. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
Ogunwobi OO; Beales IL
Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the profile of iron-management proteins in brain microvasculature.
Burdo JR; Simpson IA; Menzies S; Beard J; Connor JR
J Cereb Blood Flow Metab; 2004 Jan; 24(1):67-74. PubMed ID: 14688618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
